Merck EBIT 2012-2026 | MRK

Merck EBIT for the quarter ending March 31, 2026 was $-3.201B, a 153.92% decline year-over-year.

  • Merck 2025 EBIT was 22.107B, a 9.33% increase from 2024.
  • Merck 2024 EBIT was 20.221B, a 584.53% increase from 2023.
  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.

EBIT can be defined as earnings before interest and taxes.

Merck EBIT 2012-2026 | MRK

  • Merck 2025 EBIT was 22.107B, a 9.33% increase from 2024.
  • Merck 2024 EBIT was 20.221B, a 584.53% increase from 2023.
  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B